COVID-19: State of emergency renewed for the urban agglomeration of Montréal
MONTRÉAL, April 22, 2022 /CNW Telbec/ - In accordance with the Civil Protection Act, Montréal's executive committee has renewed the state of emergency for the urban agglomeration of Montréal on April 22, 2022, for a period of five days.
The local state of emergency, which was declared on December 21, 2021, grants exceptional powers to the urban agglomeration, enabling it to respond to the current pandemic across its territory. In particular, it gives the urban agglomeration the power to mobilize the necessary resources and workforce to fight COVID-19.
The urban agglomeration of Montréal continues to collaborate closely with its team of experts from its emergency response coordination centre, the regional public health department and the healthcare and social services network, in order to fight the spread of COVID-19.
Zinzino, the global health and wellness brand from Scandinavia, has acquired, through a business asset acquisition, the rights to the distributor database and associated customer register, inventory, and intellectual property of the Luxembourg-based...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for the...
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that it has entered into a strategic relationship with KangarooHealth, Inc. to improve patient health outcomes, as well as reduce the cost of delivering care by...
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer.
"We're not just...
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...
